Facial Thermography Study of Levocetirizine Versus Cetirizine
Completed
UCB Pharma
Phase 4
2004-07-01
Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment periods)
cross-over, double blind, double dummy, placebo controlled study to compare levocetirizine
and cetirizine by means of IR thermography.
Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis
Completed
UCB Pharma
Phase 2
2004-06-01
4 week open study to evaluate the safety of levocetirizine in young children (2 - 6 years)
suffering from allergic rhinitis. As secondary objective, this study will assess the efficacy
of the treatment by means of the T4SS (Total 4 symptoms scores of allergic rhinitis) and each
of the 4 individual rhinitis symptom scores
Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)
Completed
UCB Pharma
Phase 3
2002-03-20
The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the
efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24
months old children.
Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)
Completed
UCB Pharma SA
Phase 3
2002-03-20
The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the
efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24
months old children.
POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)
Completed
UCB Pharma
Phase 4
2005-05-01
Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as
measured by the subject's satisfaction/dissatisfaction after one week of treatment
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
